Dr. Marty Makary, the nominee to lead the Food and Drug Administration (FDA), appeared before the Senate Health, Education, Labor, and Pensions Committee (HELP) at a mostly cordial confirmation hearing on March 6.

The Johns Hopkins University surgeon and researcher fielded a plethora of questions from lawmakers on both sides of the aisle about topics ranging from the safety of abortion pills and seed oils to flu vaccines and information transparency.